Sanofi Total Stockholder Equity from 2010 to 2025
| SNY Stock | USD 54.91 0.41 0.75% |
Total Stockholder Equity | First Reported 2000-12-31 | Previous Quarter 72.7 B | Current Value 77.5 B | Quarterly Volatility 19.1 B |
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 603.9 M or Selling General Administrative of 4.9 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0235 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
Sanofi | Total Stockholder Equity |
Latest Sanofi ADR's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Sanofi ADR over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Sanofi ADR's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Sanofi Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 58,233,161,116 | |
| Geometric Mean | 51,430,398,903 | |
| Coefficient Of Variation | 28.28 | |
| Mean Deviation | 8,552,234,023 | |
| Median | 58,070,000,000 | |
| Standard Deviation | 16,469,620,107 | |
| Sample Variance | 271248386.5T | |
| Range | 73.9B | |
| R-Value | 0.62 | |
| Mean Square Error | 177998502.5T | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | 2,153,483,335 | |
| Total Sum of Squares | 4068725796.9T |
Sanofi Total Stockholder Equity History
About Sanofi ADR Financial Statements
Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 77.5 B | 51.9 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.